2023 Neuro-oncology Reading List

Reading List

Please click below to access the 2023 Neuro-oncology reading list.

C-cert Activity Description

The Continuous Certification (C-cert) activities provide subspecialty learning and knowledge assessment to ensure that diplomates are staying up to date on the latest science, treatments, and therapeutics relating to their subspecialty. The annual activities include: 1) reading the subspecialty  journal articles, and 2) taking and passing the 25-question online post-reading quiz to assess knowledge gained from the journal article content. 

Learning Objectives

• Integrate patient-centered outcomes into neuro-oncologic care management
• Appropriately apply the results gathered from large patient populations in the management of primary brain tumor patients
• Understand the prophylaxis and management of neurologic and treatment complications in primary brain tumors and brain metastases
• Understand the role and clinical implications of targeted agents in neuro-oncology

Core Competencies

• Medical Knowledge
• Patient Care
• Practice-Based Learning and Improvement

Continuing Medical Education (CME) Instructions

To claim CME credits, answer question 26 on the quiz to reflect the total time spent completing the required reading and online quiz. This question is not included in the scoring of the quiz. A passing score of 80% of higher is needed to meet C-cert requirements and receive CME credit. CME credit confirmation will be emailed within 24 hours of passing the quiz.

ACCME Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Academy of Neurology Institute (AANI) and United Council for Neurologic Subspecialties. The AANI is accredited by the ACCME to provide continuing medical education for physicians.

AMA Credit Designation Statement

The American Academy of Neurology Institute designates this enduring material for a maximum of 15 AMA PRA Category 1^TM credit(s). Physicians should claim only their credit commensurate with the extent of the participation in the activity.

ABPN Self-Assessment Designation Statement

The American Board of Psychiatry & Neurology (ABPN) has reviewed the UCNS Continuous Certification (C-cert) self-assessment activity and has approved the program as a part of a comprehensive self-assessment (SA) program, which is mandates by the American Board of Medical Specialties as a necessary component of maintenance of certification. The number of ABPN SA credits granted will equal the number of CME hours claimed for the activity. 

Disclosures

The UCNS complies with all standards and policies of the ACCME, including identification and resolution of all conflicts of interest prior to the educational activity being delivered to learners. Accordingly, UCNS  planners, authors, and staff comply with the UCNS’s Conflicts of Interest Policy. 

2023 C-cert Activity Planner Disclosures
All relevant financial relationships have been mitigated.

Neuro-oncology Certification Examination Committee Contributors

Christian Grommes, MD, Chair, Memorial Sloan Kettering Cancer Center
Disclosures: Received consultant fees from Ono, BTG, and Roche.

Andrea Wasilewski, MD, Vice Chair, Givens Brain Tumor Center
Disclosures: Nothing to disclose.

David M. Cachia, MD, UMass Memorial Medical Center
Disclosures: Received consulting fees from Red Hill BioPharma Ltd., Dedham Group, Guidepoint Global LLC; Speaker fee from Massachusetts Neurological Society. 

Yasmin Khakoo, MD, Memorial Sloan Kettering Cancer Center
Disclosures: Receive compensation as Editor-in-Chief of Pediatric Neurology; Nevus Outreach, Inc $10K annually.

Heather E. Leeper, MD, University of Chicago
Disclosures: Nothing to disclose.

Douglas E. Ney, MD, University of Colorado – Anschutz Medical Campus
Disclosures: Nothing to disclose.

Lauren Schaff, MD, Memorial Sloan Kettering Cancer Center
Disclosures: Paid Ad hoc consultant to Guidepoint consulting company; BTG, plc - financial research support Merck - research support in the form of drug supply; Patent pending related to low-dose glucarpidase with methotrexate for treatment of CNS lymphoma.

Roy E. Strowd, III, MD, Wake Forest Baptist Health
Disclosures: Received medical consulting fees for Monteris Medical. Consulting lecturer for Kaplan and Lecturio and Springer Healthcare; Compensation for serving on the data safety monitoring board for study for schwannomatosis (NCT04163419); Editorial stipend from the AAN; Research support from Jazz pharmaceuticals.

Joon Uhm, MD, Mayo Clinic – Rochester 
Disclosures: Speaker fee received from Zai Labs for educational (Zoom) sessions to review current standard of care brain tumor therapies.

Staff Contact

Bryan Hagerla, Continuous Certification Manager
Disclosures: Nothing to disclose.
[email protected]
(612) 928-6326